Drug Shortage Report for INTEGRILIN

Last updated on 2017-04-11 History
Report ID 2210
Drug Identification Number 02240351
Brand name INTEGRILIN
Common or Proper name eptifibatide injection Solution for Intravenous Infusion
Company Name MERCK CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) EPTIFIBATIDE
Strength(s) 0,75 mg/mL
Dosage form(s) Solution
Route of administration Intravenous
Packaging size 75 mg/100 mL infusion vial - Fiole de 75 mg/100 mL pour perfusion
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2016-06-27
Actual start date 2016-06-27
Estimated end date 2017-04-14
Actual end date 2017-04-10
Shortage status Resolved
Updated date 2017-04-11
Company comments Limited quantities available
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2017-04-11 English Compare
v8 2017-04-10 French Compare
v7 2017-04-10 English Compare
v6 2017-03-28 French Compare
v5 2017-03-28 English Compare
v4 2017-03-28 English Compare
v3 2017-03-14 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare

Showing 1 to 9 of 9